Skip to main content

DiaSorin Value Stock - Dividend - Research Selection

DiaSorin S.R.L.

ISIN: IT0003492391, WKN: A0MTB2

Market price date: 16.07.2021
Market price: 163,05 EUR




DiaSorin S.R.L. Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 10-04-2021
Cash flow
Net operating cash flow 304.600.000
Capital Expenditures -74.825.000
Free cash flow 229.775.008
Balance sheet
Total Equity 954.678.000
Liabilities & Shareholders equity 1.246.450.000
Income statement
Net income 247.871.000
Eps (diluted) 4,500
Diluted shares outstanding 54.764.400
Net sales/revenue 881.305.000

Fundamental ratios calculated on: 16-07-2021

Ratios
Key figures 16-07-2021
Cash flow
P/C 29,32
   
P/FC 38,86
Balance sheet
ROI19,89
ROE76,59
Income statement
P/E36,23
Div. Yield0,00%
P/B9,35
P/S10,13


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolDIA.MI
Market Capitalization10.830.000.128,00 USD
Country
IndicesFTSE MIB
Sectors
Raw Data SourceIFRS in Millionen EUR
Stock Split
Internetwww.diasorin.com


Description of the company

DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. Its immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips; and ETI Max 3000, an automated microtiter plate analyzer. The company also offers molecular diagnostic products for oncology, hematology, and infectious diseases; systems, including BULLET Pro and LIAISON Ixt to extract the nucleic acid from various biological samples; and LIAISON Iam to diagnose and various infectious diseases and onco-hematology parameters. It sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.diasorin.com